Capricor’s DMD Cell Therapy Faces FDA Setback
The developer of a new cell therapy for Duchenne muscular dystrophy (DMD) says it will continue to push for FDA...
The developer of a new cell therapy for Duchenne muscular dystrophy (DMD) says it will continue to push for FDA...